Onward Medical N.V. - ONWD.BR - Fundamentals

‌
‌

‌

Let's get started...

‌

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	1	1	1	2	1	0	4	4	📊
Revenue Growth (1Y)	--	+16.88%	+44.40%	+74.88%	+53.54%	-75.23%	-85.53%	+4809.09%	--	📊
Revenue Growth (5Y)	--	--	--	--	+353.16%	-3.97%	-90.38%	+170.19%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	1	1	2	4	15	15	1	1	1	📊
Cost of Revenue Growth (1Y)	--	-19.50%	+175.54%	+75.27%	+262.91%	+4.51%	-94.01%	+12.93%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+1310.85%	+1731.74%	-60.16%	-74.33%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	-1	-0	-2	-3	-13	-15	-1	3	3	📊
Gross Profit Growth (1Y)	--	+49.91%	-431.34%	-75.48%	-373.53%	-18.18%	+94.31%	+425.15%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	-2111.46%	-5117.61%	+44.14%	+203.51%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	7	10	13	24	17	21	36	44	44	📊
Operating Expenses Growth (1Y)	--	+34.90%	+32.92%	+85.44%	-29.18%	+19.05%	+72.83%	+22.35%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+135.48%	+107.82%	+170.23%	+78.30%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	1	3	3	8	10	16	23	10	10	📊
Research and Development	5	5	6	8	13	14	12	12	12	📊
Other Income Expenses	1	2	4	9	7	-9	0	22	22	📊
EBITDA	-8	-11	-15	-28	-31	-35	-33	-38	-38	📊
EBITDA Growth (1Y)	--	-28.96%	-45.09%	-85.07%	-10.43%	-12.73%	+6.72%	-15.05%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-282.42%	-234.29%	-114.92%	-33.61%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	1	0	1	1	1	📊
Operating Income	-8	-11	-16	-29	-32	-35	-37	-41	-41	📊
Operating Income Growth (1Y)	--	-28.16%	-44.00%	-83.94%	-12.25%	-10.72%	-2.99%	-12.02%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-281.06%	-229.21%	-135.46%	-43.40%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	1	3	4	6	2	1	2	2	2	📊
Pre Tax Income	-10	-13	-20	-34	-34	-36	-36	-41	-41	📊
Tax Provision	0	0	0	0	-1	0	-0	0	--	📊
NET INCOME	-10	-13	-20	-34	-33	-36	-36	-42	-42	📊
Net Income Growth (1Y)	--	-36.03%	-48.44%	-71.45%	+4.49%	-10.40%	+1.26%	-16.97%	--	📊
Net Income Growth (5Y)	--	--	--	--	-230.63%	-168.35%	-78.50%	-21.78%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.48	-0.65	-0.96	-1.14	-1.09	-1.2	-0.8	0	-0.94	📊
Diluted EPS	-0.48	-0.65	-0.96	-1.14	-1.09	-1.2	0	0	-0.94	📊
Basic Average Shares	21	21	21	30	30	30	45	0	45	📊
Diluted Average Shares	21	21	21	30	30	30	45	0	45	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+16.88%

+44.40%

+74.88%

+53.54%

-75.23%

-85.53%

+4809.09%

📊

Revenue Growth (5Y)

+353.16%

-3.97%

-90.38%

+170.19%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-19.50%

+175.54%

+75.27%

+262.91%

+4.51%

-94.01%

+12.93%

📊

Cost of Revenue Growth (5Y)

+1310.85%

+1731.74%

-60.16%

-74.33%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-1

-0

-2

-3

-13

-15

-1

📊

Gross Profit Growth (1Y)

+49.91%

-431.34%

-75.48%

-373.53%

-18.18%

+94.31%

+425.15%

📊

Gross Profit Growth (5Y)

-2111.46%

-5117.61%

+44.14%

+203.51%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+34.90%

+32.92%

+85.44%

-29.18%

+19.05%

+72.83%

+22.35%

📊

Operating Expenses Growth (5Y)

+135.48%

+107.82%

+170.23%

+78.30%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-9

📊

EBITDA

-8

-11

-15

-28

-31

-35

-33

-38

📊

EBITDA Growth (1Y)

-28.96%

-45.09%

-85.07%

-10.43%

-12.73%

+6.72%

-15.05%

📊

EBITDA Growth (5Y)

-282.42%

-234.29%

-114.92%

-33.61%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-8

-11

-16

-29

-32

-35

-37

-41

📊

Operating Income Growth (1Y)

-28.16%

-44.00%

-83.94%

-12.25%

-10.72%

-2.99%

-12.02%

📊

Operating Income Growth (5Y)

-281.06%

-229.21%

-135.46%

-43.40%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-10

-13

-20

-34

-36

-41

📊

Tax Provision

-1

-0

📊

NET INCOME

-10

-13

-20

-34

-33

-36

-42

📊

Net Income Growth (1Y)

-36.03%

-48.44%

-71.45%

+4.49%

-10.40%

+1.26%

-16.97%

📊

Net Income Growth (5Y)

-230.63%

-168.35%

-78.50%

-21.78%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.48

-0.65

-0.96

-1.14

-1.09

-1.2

-0.8

-0.94

📊

Diluted EPS

-0.48

-0.65

-0.96

-1.14

-1.09

-1.2

-0.94

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	1	1	1	2	1	0	4	4	📊
Revenue Growth (1Y)	--	+16.88%	+44.40%	+74.88%	+53.54%	-75.23%	-85.53%	+4809.09%	--	📊
Revenue Growth (5Y)	--	--	--	--	+353.16%	-3.97%	-90.38%	+170.19%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	1	1	2	4	15	15	1	1	1	📊
Cost of Revenue Growth (1Y)	--	-19.50%	+175.54%	+75.27%	+262.91%	+4.51%	-94.01%	+12.93%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+1310.85%	+1731.74%	-60.16%	-74.33%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	-1	-0	-2	-3	-13	-15	-1	3	3	📊
Gross Profit Growth (1Y)	--	+49.91%	-431.34%	-75.48%	-373.53%	-18.18%	+94.31%	+425.15%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	-2111.46%	-5117.61%	+44.14%	+203.51%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	7	10	13	24	17	21	36	44	44	📊
Operating Expenses Growth (1Y)	--	+34.90%	+32.92%	+85.44%	-29.18%	+19.05%	+72.83%	+22.35%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+135.48%	+107.82%	+170.23%	+78.30%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	1	3	3	8	10	16	23	10	10	📊
Research and Development	5	5	6	8	13	14	12	12	12	📊
Other Income Expenses	1	2	4	9	7	-9	0	22	22	📊
EBITDA	-8	-11	-15	-28	-31	-35	-33	-38	-38	📊
EBITDA Growth (1Y)	--	-28.96%	-45.09%	-85.07%	-10.43%	-12.73%	+6.72%	-15.05%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-282.42%	-234.29%	-114.92%	-33.61%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	1	0	1	1	1	📊
Operating Income	-8	-11	-16	-29	-32	-35	-37	-41	-41	📊
Operating Income Growth (1Y)	--	-28.16%	-44.00%	-83.94%	-12.25%	-10.72%	-2.99%	-12.02%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-281.06%	-229.21%	-135.46%	-43.40%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	1	3	4	6	2	1	2	2	2	📊
Pre Tax Income	-10	-13	-20	-34	-34	-36	-36	-41	-41	📊
Tax Provision	0	0	0	0	-1	0	-0	0	--	📊
NET INCOME	-10	-13	-20	-34	-33	-36	-36	-42	-42	📊
Net Income Growth (1Y)	--	-36.03%	-48.44%	-71.45%	+4.49%	-10.40%	+1.26%	-16.97%	--	📊
Net Income Growth (5Y)	--	--	--	--	-230.63%	-168.35%	-78.50%	-21.78%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.48	-0.65	-0.96	-1.14	-1.09	-1.2	-0.8	0	-0.94	📊
Diluted EPS	-0.48	-0.65	-0.96	-1.14	-1.09	-1.2	0	0	-0.94	📊
Basic Average Shares	21	21	21	30	30	30	45	0	45	📊
Diluted Average Shares	21	21	21	30	30	30	45	0	45	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+16.88%

+44.40%

+74.88%

+53.54%

-75.23%

-85.53%

+4809.09%

📊

Revenue Growth (5Y)

+353.16%

-3.97%

-90.38%

+170.19%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-19.50%

+175.54%

+75.27%

+262.91%

+4.51%

-94.01%

+12.93%

📊

Cost of Revenue Growth (5Y)

+1310.85%

+1731.74%

-60.16%

-74.33%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-1

-0

-2

-3

-13

-15

-1

📊

Gross Profit Growth (1Y)

+49.91%

-431.34%

-75.48%

-373.53%

-18.18%

+94.31%

+425.15%

📊

Gross Profit Growth (5Y)

-2111.46%

-5117.61%

+44.14%

+203.51%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+34.90%

+32.92%

+85.44%

-29.18%

+19.05%

+72.83%

+22.35%

📊

Operating Expenses Growth (5Y)

+135.48%

+107.82%

+170.23%

+78.30%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-9

📊

EBITDA

-8

-11

-15

-28

-31

-35

-33

-38

📊

EBITDA Growth (1Y)

-28.96%

-45.09%

-85.07%

-10.43%

-12.73%

+6.72%

-15.05%

📊

EBITDA Growth (5Y)

-282.42%

-234.29%

-114.92%

-33.61%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-8

-11

-16

-29

-32

-35

-37

-41

📊

Operating Income Growth (1Y)

-28.16%

-44.00%

-83.94%

-12.25%

-10.72%

-2.99%

-12.02%

📊

Operating Income Growth (5Y)

-281.06%

-229.21%

-135.46%

-43.40%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-10

-13

-20

-34

-36

-41

📊

Tax Provision

-1

-0

📊

NET INCOME

-10

-13

-20

-34

-33

-36

-42

📊

Net Income Growth (1Y)

-36.03%

-48.44%

-71.45%

+4.49%

-10.40%

+1.26%

-16.97%

📊

Net Income Growth (5Y)

-230.63%

-168.35%

-78.50%

-21.78%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.48

-0.65

-0.96

-1.14

-1.09

-1.2

-0.8

-0.94

📊

Diluted EPS

-0.48

-0.65

-0.96

-1.14

-1.09

-1.2

-0.94

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	--
Next Earnings
Market cap	126.32M (EUR)
EPS (TTM)	-0.94 (€)
P/E (TTM)	-3.01 (€)
Last Close	2.83

Next Earnings
Market cap	126.32M (EUR)
EPS (TTM)	-0.94 (€)
P/E (TTM)	-3.01 (€)
Last Close	2.83 (€)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	--
Next Earnings
Market cap	126.32M (EUR)
EPS (TTM)	-0.94 (€)
P/E (TTM)	-3.01 (€)
Last Close	2.83

Next Earnings
Market cap	126.32M (EUR)
EPS (TTM)	-0.94 (€)
P/E (TTM)	-3.01 (€)
Last Close	2.83 (€)